Diabetic Retinopathy: Targeting BIGH3 to Develop Novel Molecular Therapies

Authors

Reanna Rodriguez, The University of Texas Rio Grande Valley
Anjalee Choudhury, The University of Texas Rio Grande Valley
Daniela Gonzalez, The University of Texas Rio Grande Valley
Cristian Mercado, The University of Texas Rio Grande Valley
Andrew Tsin, The University of Texas Rio Grande Valley

Document Type

Editorial

Publication Date

5-2020

Abstract

Diabetic retinopathy (DR) is a complication of diabetes due to damage of blood vessels in the retina. Aside from being a major cause of blindness in the world, DR also has a significant impact on quality of life. Although there are methods to delay the progression of DR, there are no existing therapeutic regimens for early intervention. Thus, it is critical to develop cost-effective therapies towards preventing DR development.

Comments

© All rights are reserved by Reanna Rodriguez

Recommended Citation

Reanna R, Anjalee C, Daniela G, Cristian M, Andrew T. Diabetic Retinopathy: Targeting BIGH3 to Develop Novel Molecular Therapies. W J Opthalmol & Vision Res. 3(2): 2020. WJOVR.MS.ID.000558. DOI: 10.33552/WJOVR.2020.03.000558

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Publication Title

World Journal of Ophthalmology & Vision Research

DOI

10.33552/WJOVR.2020.03.000558

Academic Level

medical student

Mentor/PI Department

Molecular Science